These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22197611)

  • 1. Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase.
    Petzer A; Harvey BH; Wegener G; Petzer JP
    Toxicol Appl Pharmacol; 2012 Feb; 258(3):403-9. PubMed ID: 22197611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase.
    Petzer A; Harvey BH; Petzer JP
    Toxicol Appl Pharmacol; 2014 Feb; 274(3):488-93. PubMed ID: 24161345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azure B and a synthetic structural analogue of methylene blue, ethylthioninium chloride, present with antidepressant-like properties.
    Delport A; Harvey BH; Petzer A; Petzer JP
    Life Sci; 2014 Nov; 117(2):56-66. PubMed ID: 25445435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The monoamine oxidase inhibition properties of selected structural analogues of methylene blue.
    Delport A; Harvey BH; Petzer A; Petzer JP
    Toxicol Appl Pharmacol; 2017 Jun; 325():1-8. PubMed ID: 28377303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine oxidase inhibition by selected dye compounds.
    de Beer F; Petzer JP; Petzer A
    Chem Biol Drug Des; 2020 Mar; 95(3):355-367. PubMed ID: 31834986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction.
    Ramsay RR; Dunford C; Gillman PK
    Br J Pharmacol; 2007 Nov; 152(6):946-51. PubMed ID: 17721552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase inhibition by selected anilide derivatives.
    Legoabe L; Kruger J; Petzer A; Bergh JJ; Petzer JP
    Eur J Med Chem; 2011 Oct; 46(10):5162-74. PubMed ID: 21899930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues.
    Strydom B; Malan SF; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2010 Feb; 18(3):1018-28. PubMed ID: 20093036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B.
    Yoshida S; Rosen TC; Meyer OG; Sloan MJ; Ye S; Haufe G; Kirk KL
    Bioorg Med Chem; 2004 May; 12(10):2645-52. PubMed ID: 15110846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B.
    Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6632-5. PubMed ID: 23010267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interactions of caffeine with monoamine oxidase.
    Petzer A; Pienaar A; Petzer JP
    Life Sci; 2013 Aug; 93(7):283-7. PubMed ID: 23850513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B.
    Van der Walt MM; Terre'Blanche G; Lourens AC; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7367-70. PubMed ID: 23122857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors.
    Herraiz T; Guillén H
    Food Chem Toxicol; 2011 Aug; 49(8):1773-81. PubMed ID: 21554916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Aryl- and alkyloxycaffeine analogues as inhibitors of monoamine oxidase.
    Strydom B; Bergh JJ; Petzer JP
    Eur J Med Chem; 2011 Aug; 46(8):3474-85. PubMed ID: 21621312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylene Blue Analogues with Marginal Monoamine Oxidase Inhibition Retain Antidepressant-like Activity.
    Delport A; Harvey BH; Petzer A; Petzer JP
    ACS Chem Neurosci; 2018 Dec; 9(12):2917-2928. PubMed ID: 29976053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human monoamine oxidase A and B by 5-phenoxy 8-aminoquinoline analogs.
    Chaurasiya ND; Ganesan S; Nanayakkara NP; Dias LR; Walker LA; Tekwani BL
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1701-4. PubMed ID: 22264472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of monoamine oxidase, nitric oxide synthase and regional brain monoamines in the antidepressant-like effects of methylene blue and selected structural analogues.
    Harvey BH; Duvenhage I; Viljoen F; Scheepers N; Malan SF; Wegener G; Brink CB; Petzer JP
    Biochem Pharmacol; 2010 Nov; 80(10):1580-91. PubMed ID: 20699087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Santana L; González-Díaz H; Quezada E; Uriarte E; Yáñez M; Viña D; Orallo F
    J Med Chem; 2008 Nov; 51(21):6740-51. PubMed ID: 18834112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors.
    Herraiz T; Chaparro C
    Biochem Biophys Res Commun; 2005 Jan; 326(2):378-86. PubMed ID: 15582589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.